Spots Global Cancer Trial Database for Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Official Title: A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)
Study ID: NCT03239223
Interventions
Study Description
Brief Summary: This study evaluates the use of topical ABI-1968 cream, in the treatment of cervical precancerous lesions in adult women.
Detailed Description:
Keywords
Eligibility
Minimum Age: 25 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Center, Los Angeles, California, United States
Research Center, Lake Worth, Florida, United States
Research Center, Idaho Falls, Idaho, United States
Research Center, Chapel Hill, North Carolina, United States
Research Center, Winston-Salem, North Carolina, United States
Research Center, Norfolk, Virginia, United States
Research Center, Camperdown, New South Wales, Australia
Research Center, Darlinghurst, New South Wales, Australia
Research Center, South Brisbane, Queensland, Australia
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
